MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis
Open Access
- 3 October 2023
- journal article
- retracted article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1215194
Abstract
Gynecologic cancer is a significant cause of death in women worldwide, with cervical cancer, ovarian cancer, and endometrial cancer being among the most well-known types. The initiation and progression of gynecologic cancers involve a variety of biological functions, including angiogenesis and metastasis—given that death mostly occurs from metastatic tumors that have invaded the surrounding tissues. Therefore, understanding the molecular pathways underlying gynecologic cancer metastasis is critical for enhancing patient survival and outcomes. Recent research has revealed the contribution of numerous non-coding RNAs (ncRNAs) to metastasis and invasion of gynecologic cancer by affecting specific cellular pathways. This review focuses on three types of gynecologic cancer (ovarian, endometrial, and cervical) and three kinds of ncRNAs (long non-coding RNAs, microRNAs, and circular RNAs). We summarize the detailed role of non-coding RNAs in the different pathways and molecular interactions involved in the invasion and metastasis of these cancers.Keywords
This publication has 416 references indexed in Scilit:
- Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen depositionBMC Cancer, 2014
- miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancersBMC Genomics, 2013
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- The E3 Ligase Axotrophin/MARCH-7: Protein Expression Profiling of Human Tissues Reveals Links to Adult Stem CellsJournal of Histochemistry & Cytochemistry, 2009
- A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA clusterBlood, 2009
- Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 InhibitorClinical Cancer Research, 2008
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor SuperfamilyScience, 1995